| 摘要 |
Provided are: a component for exhibiting the effect of improving or optimizing the intestinal environment of an organism, or preventing intestinal rot, or preventing abnormal reproduction of intestinal cells and/or preventing pathological changes thereof; an active ingredient which is favorable used in the treatment of intestinal patients; and a monoclonal IgA antibody which bonds to the amino acid in the 1-333 position of serine hydroxymethyltransferase. |
